Loading...
Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia
BACKGROUND: Tobacco smoking is the leading preventable cause of morbidity and mortality in Australia and other developed countries. Of the pharmacological aids that are available for smoking cessation, bupropion (Zyban SR) is eligible for public reimbursement on the Australian Pharmaceutical Benefit...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Group
2007
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2598534/ https://ncbi.nlm.nih.gov/pubmed/17652241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/tc.2006.017657 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|